BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7792033)

  • 1. Role of protein adsorption on haemodialysis-induced complement activation and neutrophil defects.
    Neveceral P; Markert M; Wauters JP
    Nephrol Dial Transplant; 1995; 10(3):372-6. PubMed ID: 7792033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation and neutrophil aggregation changes during haemodialysis.
    Kubatiev A; Rudko I; Ermolenko V
    Int J Clin Pharmacol Res; 1993; 13(6):293-9. PubMed ID: 8088929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation and leucopenia on cellulosic haemodialyzers: influence of the membrane area and role of hydroxyl moieties.
    Goldman M; Lietaer N; Lambert P; Thayse C; Vanherweghem JL
    Life Support Syst; 1987; 5(4):317-22. PubMed ID: 3501504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis of human polymorphonuclear neutrophils accelerated by dialysis membranes via the activation of the complement system.
    Koller H; Hochegger K; Zlabinger GJ; Lhotta K; Mayer G; Rosenkranz AR
    Nephrol Dial Transplant; 2004 Dec; 19(12):3104-11. PubMed ID: 15575000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucopenia, hypoxia and complement activation in haemodialysis. Three unrelated phenomena.
    de Vinuesa SG; Resano M; Luño J; Gonzalez C; Barril G; Junco E; Valderrabano F
    Proc Eur Dial Transplant Assoc; 1983; 19():159-67. PubMed ID: 6878230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodialysis-induced leucopenia and activation of complement: effects of different membranes.
    Aljama P; Bird PA; Ward MK; Feest TG; Walker W; Tanboga H; Sussman M; Kerr DN
    Proc Eur Dial Transplant Assoc; 1978; 15():144-53. PubMed ID: 740661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal leucocyte locomotion induced by haemodialysis membranes. A clue to dialysis leucopenia.
    Losito A; Buoncristiani U; Cecchini C
    J Clin Lab Immunol; 1983 Feb; 10(2):87-90. PubMed ID: 6601717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocompatibility aspects of dialyzer reprocessing: a comparison of 3 re-use methods and 3 membranes.
    Kuwahara T; Markert M; Wauters JP
    Clin Nephrol; 1989 Sep; 32(3):139-43. PubMed ID: 2791365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [C-reactive protein (CRP) as a marker of of hemodialysis biocompatibility].
    Szepietowski T; Krajewska M
    Polim Med; 1997; 27(1-2):47-59. PubMed ID: 9380601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil behavior during hemodialysis. Role of membrane contact.
    Neveceral P; Markert M; Wauters JP
    ASAIO Trans; 1988; 34(3):564-7. PubMed ID: 2848563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meltspun cellulose diacetate and polysulfone membranes have the same effect on complement activation and expression of leukocyte adhesion molecules and complement receptors.
    Dameche L; Brunet P; George F; André-Pinon S; Bernard D; Sampol J; Berland Y
    Nephrol Dial Transplant; 1995; 10 Suppl 10():33-8. PubMed ID: 8825430
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of dialyzer geometry on blood coagulation and biocompatibility.
    Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R
    Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediators of complement-independent granulocyte activation during haemodialysis: role of calcium, prostaglandins and leukotrienes.
    Böhler J; Donauer J; Birmelin M; Schollmeyer PJ; Hörl WH
    Nephrol Dial Transplant; 1993; 8(12):1359-65. PubMed ID: 8159305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes.
    Mandolfo S; Tetta C; David S; Gervasio R; Ognibene D; Wratten ML; Tessore E; Imbasciati E
    Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical sequelae of complement activation in hemodialysis.
    Hakim RM
    Clin Nephrol; 1986; 26 Suppl 1():S9-12. PubMed ID: 3829474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interaction between blood and dialysis membrane].
    Szepietowski T; Orłowski A
    Polim Med; 1991; 21(3-4):3-13. PubMed ID: 1822594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility of hemodialysis membranes: evaluation in an ovine model.
    Burhop KE; Johnson RJ; Simpson J; Chenoweth DE; Borgia J
    J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical study on different cellulosic dialysis membranes.
    Falkenhagen D; Bosch T; Brown GS; Schmidt B; Holtz M; Baurmeister U; Gurland H; Klinkmann H
    Nephrol Dial Transplant; 1987; 2(6):537-45. PubMed ID: 3126455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.